Annual SGA
$77.11 M
+$26.54 M+52.49%
December 31, 2024
Summary
- As of March 6, 2025, KURA annual SGA is $77.11 million, with the most recent change of +$26.54 million (+52.49%) on December 31, 2024.
- During the last 3 years, KURA annual SGA has risen by +$30.57 million (+65.70%).
- KURA annual SGA is now at all-time high.
Performance
KURA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$24.07 M
+$5.89 M+32.41%
December 31, 2024
Summary
- As of March 6, 2025, KURA quarterly SGA is $24.07 million, with the most recent change of +$5.89 million (+32.41%) on December 31, 2024.
- Over the past year, KURA quarterly SGA has increased by +$9.84 million (+69.17%).
- KURA quarterly SGA is now at all-time high.
Performance
KURA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.36 B
-$173.98 M-5.45%
December 31, 2024
Summary
- As of March 6, 2025, KURA TTM SGA is -$3.36 billion, with the most recent change of -$173.98 million (-5.45%) on December 31, 2024.
- Over the past year, KURA TTM SGA has dropped by -$3.41 billion (-6753.07%).
- KURA TTM SGA is now -16873.02% below its all-time high of -$19.82 million.
Performance
KURA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
KURA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.5% | +69.2% | -6753.1% |
| 3 y3 years | +65.7% | +69.2% | -6753.1% |
| 5 y5 years | +292.4% | +69.2% | -6753.1% |
KURA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.7% | at high | +117.3% | -119.4% | at low |
| 5 y | 5-year | at high | +292.4% | at high | +337.7% | -348.5% | at low |
| alltime | all time | at high | +1166.6% | at high | +2170.8% | <-9999.0% | at low |
Kura Oncology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $77.11 M(+52.5%) | $24.07 M(+32.4%) | $77.11 M(+14.6%) |
| Sep 2024 | - | $18.18 M(+9.0%) | $67.27 M(+8.1%) |
| Jun 2024 | - | $16.68 M(-8.3%) | $62.23 M(+8.5%) |
| Mar 2024 | - | $18.18 M(+27.8%) | $57.38 M(+13.5%) |
| Dec 2023 | $50.57 M(+7.5%) | $14.23 M(+8.2%) | $50.57 M(+3.6%) |
| Sep 2023 | - | $13.14 M(+11.2%) | $48.83 M(+3.2%) |
| Jun 2023 | - | $11.82 M(+3.9%) | $47.30 M(+1.6%) |
| Mar 2023 | - | $11.37 M(-8.9%) | $46.56 M(-1.1%) |
| Dec 2022 | $47.05 M(+1.1%) | $12.49 M(+7.5%) | $47.05 M(+0.9%) |
| Sep 2022 | - | $11.62 M(+4.9%) | $46.65 M(+0.7%) |
| Jun 2022 | - | $11.07 M(-6.7%) | $46.34 M(-3.1%) |
| Mar 2022 | - | $11.87 M(-1.8%) | $47.83 M(+2.8%) |
| Dec 2021 | $46.54 M(+47.7%) | $12.08 M(+6.8%) | $46.54 M(+7.6%) |
| Sep 2021 | - | $11.31 M(-10.0%) | $43.26 M(+9.4%) |
| Jun 2021 | - | $12.57 M(+18.9%) | $39.55 M(+14.8%) |
| Mar 2021 | - | $10.57 M(+20.0%) | $34.45 M(+9.4%) |
| Dec 2020 | $31.50 M(+60.3%) | $8.81 M(+16.0%) | $31.50 M(+11.7%) |
| Sep 2020 | - | $7.59 M(+1.6%) | $28.19 M(+9.6%) |
| Jun 2020 | - | $7.48 M(-2.0%) | $25.73 M(+13.3%) |
| Mar 2020 | - | $7.63 M(+38.7%) | $22.71 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $19.65 M(+22.1%) | $5.50 M(+7.1%) | $19.65 M(+5.1%) |
| Sep 2019 | - | $5.13 M(+15.3%) | $18.70 M(+4.5%) |
| Jun 2019 | - | $4.45 M(-2.6%) | $17.89 M(+3.8%) |
| Mar 2019 | - | $4.57 M(+0.4%) | $17.24 M(+7.1%) |
| Dec 2018 | $16.10 M(+66.8%) | $4.55 M(+5.3%) | $16.10 M(+11.6%) |
| Sep 2018 | - | $4.32 M(+13.7%) | $14.42 M(+15.8%) |
| Jun 2018 | - | $3.80 M(+10.9%) | $12.46 M(+13.9%) |
| Mar 2018 | - | $3.42 M(+19.1%) | $10.94 M(+13.3%) |
| Dec 2017 | $9.65 M(+21.2%) | $2.88 M(+22.0%) | $9.65 M(+10.3%) |
| Sep 2017 | - | $2.36 M(+3.5%) | $8.75 M(+7.6%) |
| Jun 2017 | - | $2.28 M(+6.4%) | $8.13 M(+5.5%) |
| Mar 2017 | - | $2.14 M(+8.4%) | $7.71 M(-3.2%) |
| Dec 2016 | $7.96 M(+30.8%) | $1.98 M(+13.4%) | $7.96 M(+3.2%) |
| Sep 2016 | - | $1.74 M(-6.1%) | $7.72 M(-0.7%) |
| Jun 2016 | - | $1.85 M(-22.4%) | $7.77 M(+4.7%) |
| Mar 2016 | - | $2.39 M(+38.3%) | $7.42 M(+21.9%) |
| Dec 2015 | $6.09 M | $1.73 M(-3.6%) | $6.09 M(+39.7%) |
| Sep 2015 | - | $1.79 M(+19.1%) | $4.36 M(+69.9%) |
| Jun 2015 | - | $1.51 M(+42.1%) | $2.57 M(+142.1%) |
| Mar 2015 | - | $1.06 M | $1.06 M |
FAQ
- What is Kura Oncology annual SGA?
- What is the all time high annual SGA for Kura Oncology?
- What is Kura Oncology annual SGA year-on-year change?
- What is Kura Oncology quarterly SGA?
- What is the all time high quarterly SGA for Kura Oncology?
- What is Kura Oncology quarterly SGA year-on-year change?
- What is Kura Oncology TTM SGA?
- What is the all time high TTM SGA for Kura Oncology?
- What is Kura Oncology TTM SGA year-on-year change?
What is Kura Oncology annual SGA?
The current annual SGA of KURA is $77.11 M
What is the all time high annual SGA for Kura Oncology?
Kura Oncology all-time high annual SGA is $77.11 M
What is Kura Oncology annual SGA year-on-year change?
Over the past year, KURA annual SGA has changed by +$26.54 M (+52.49%)
What is Kura Oncology quarterly SGA?
The current quarterly SGA of KURA is $24.07 M
What is the all time high quarterly SGA for Kura Oncology?
Kura Oncology all-time high quarterly SGA is $24.07 M
What is Kura Oncology quarterly SGA year-on-year change?
Over the past year, KURA quarterly SGA has changed by +$9.84 M (+69.17%)
What is Kura Oncology TTM SGA?
The current TTM SGA of KURA is -$3.36 B
What is the all time high TTM SGA for Kura Oncology?
Kura Oncology all-time high TTM SGA is -$19.82 M
What is Kura Oncology TTM SGA year-on-year change?
Over the past year, KURA TTM SGA has changed by -$3.41 B (-6753.07%)